What antibiotics are effective against vibrio cholerae?
Best insight from top research papers
Aztreonam, cefepime, and imipenem are effective antibiotics against Vibrio cholerae . Other effective antibiotics include azithromycin, gentamicin, cephalexin, ofloxacin, norfloxacin, fluoroquinolones, ceftriaxone, doxycycline, kanamycin, and cefotaxime . However, there is an increasing resistance to antibiotics such as cephalothin, ceftriaxone, amoxicillin, meropenem, nalidixic acid, cotrimoxazole, furazolidone, and tetracycline . It is important to note that the effectiveness of antibiotics may vary based on the geographic area and the year of the study . Continuous surveillance, appropriate antimicrobial susceptibility testing, and limitation on improper antibiotic usage are crucial to address the rise of antimicrobial resistance in Vibrio cholerae strains .
Answers from top 4 papers
More filters
| Papers (4) | Insight |
|---|---|
| The paper states that fluoroquinolones, gentamicin, ceftriaxone, doxycycline, kanamycin, and cefotaxime showed the highest effectiveness against Vibrio cholerae. | |
| The paper states that the Vibrio cholerae O1 strains showed resistance to several antibiotics, but cyclins, quinolones, and macrolides remained relatively sensitive. The specific antibiotics that are effective against Vibrio cholerae are not mentioned in the paper. | |
2 Citations | The paper states that ciprofloxacin, azithromycin, gentamicin, cephalexin, imipenem, ofloxacin, and norfloxacin are the best antibiotics against Vibrio cholerae. |
| Aztreonam, cefepime, and imipenem are the most effective antibiotics against Vibrio cholerae according to the provided paper. |
Related Questions
What is the antibiotic of choice against Shigella spp?5 answersCiprofloxacin is the antibiotic of choice against Shigella spp..
How do cephalosporin antibiotics work in treating Vibrio infections?5 answersCephalosporin antibiotics are effective in treating Vibrio infections. These antibiotics have a broad spectrum of activity against gram-negative microorganisms, including Vibrio species. The mechanism of action of cephalosporins involves the inhibition of bacterial cell wall synthesis. They have a β-lactam structure that allows them to bind to penicillin-binding proteins (PBPs) in the bacterial cell wall, leading to the disruption of peptidoglycan synthesis and cell wall integrity. This ultimately results in bacterial cell death. Cephalosporins have been shown to be highly active against gram-negative bacteria, making them suitable for the treatment of Vibrio infections. Additionally, cephalosporins have been modified to enhance their antibacterial spectrum and pharmacokinetic properties, further improving their efficacy against Vibrio species. Therefore, cephalosporin antibiotics are a valuable treatment option for Vibrio infections due to their broad spectrum of activity and ability to inhibit bacterial cell wall synthesis.
What are the future treatments for cholera?5 answersNew treatments for cholera are being explored in the literature. These include molecules that offer protection against cholera toxin-induced diarrhea or V. cholerae infection, such as receptor regulator cystic fibrosis channel transmembrane (CFTR), monosialoganglioside (GM1), enkephalinase, AMP-activated protein kinase (AMPK), inhibitors of virulence factors, and activators of ADP-ribosylarginine hydrolase. Additionally, there are suggestions to reduce stool output and fluid requirements by restricting oral rehydration solution (ORS) intake to match stool output, promoting intestinal reabsorption of luminal fluid by early introduction of glucose without salts into the intestine, correcting dehydration more gradually, giving mineralocorticoid and vasopressin, and infusing glucose or short-chain fatty acids into the proximal colon. In the future, new treatment options for managing severe diarrhea in cholera could be available, including inhibitors of enkephalinase and the cystic fibrosis transmembrane conductance regulator.
What is the drug of choice for Acinetobacter baumannii?5 answersColistin is currently the most effective drug for treating multidrug-resistant Acinetobacter baumannii (MDRAB) infections. However, new drugs and treatment protocols are urgently needed as many previously effective drugs have lost their effectiveness against MDRAB. PBT2, an 8-hydroxquinoline ionophore, has shown promise in breaking the resistance of A. baumannii to tetracycline class antibiotics. Combination therapy with PBT2 and tetracycline or tigecycline has been shown to be bactericidal against MDRAB in vitro and in a murine model of pulmonary infection. Polymyxin-based combination therapies with either a carbapenem, minocycline, or eravacycline remain the treatment of choice for MDRAB infections. Imipenem/relebactam provides a therapy option for treating multidrug-resistant Pseudomonas aeruginosa but not A. baumannii infections in China.
Isolation of vibrio cholera in water sample5 answersIsolation of Vibrio cholerae in water samples was reported in multiple studies. In Lake Tanganyika, Tanzania, V. cholerae was detected in sardine samples (9%) and water samples (3%). In Douala, Cameroon, V. cholerae was isolated from wells and a stream, with higher isolation rates during the rainy season. In Haiti, toxigenic V. cholerae was recovered from surface waters more than 2 years after the onset of the epidemic. An immunofluorescent-aggregation (IFAG) assay was developed to detect V. cholerae in estuarine water samples, showing a sensitivity of 10(3) CFU/ml. In Bangladesh, the isolation of V. cholerae from surface waters was improved by using enrichment media containing autoinducers.
What is the antibiotics of choice for V. cholera treatment?3 answersThe antibiotics of choice for V. cholera treatment are tetracycline, doxycycline, norfloxacin, ciprofloxacin, and furazolidone. These antibiotics can be used as an adjunct to rehydration therapy to reduce the rate of stool output, shorten the duration of hospital stay, and minimize the requirement of fluids. Tetracycline has been used effectively for many years, but resistant strains of V. cholerae have emerged in some countries. Other antibiotics such as doxycycline, norfloxacin, ciprofloxacin, and furazolidone have also been found to be clinically useful in the treatment of severe cholera. It is important to note that the choice of antibiotic may vary depending on the geographical region and the resistance patterns of V. cholerae in that area. Monitoring antibiotic resistance and prescribing appropriate antibiotics are vital to control resistance and ensure effective treatment.